About Medinice
Medinice is a company based in Kielce (Poland) founded in 2012. Medinice has raised $2.46 million across 2 funding rounds. Medinice offers products and services including PacePress and CoolCryo.
- Headquarter Kielce, Poland
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Medinice Sa
-
Annual Revenue
$45.69 K (USD)-16.44as on Dec 31, 2024
-
Net Profit
$9.13 M (USD)0as on Dec 31, 2024
-
EBITDA
-$1.08 M (USD)18.02as on Dec 31, 2024
-
Total Equity Funding
$2.46 M (USD)
in 2 rounds
-
Latest Funding Round
$1.35 M (USD), Series A
Sep 01, 2018
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Medinice
Medinice is a publicly listed company on the GPW with ticker symbol ICE in Poland, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Medinice
Medinice offers a comprehensive portfolio of products and services, including PacePress and CoolCryo.
PacePress is utilized for faster recovery after CIED implantations in cardiology.
CoolCryo is employed as a method for treating heart conditions through cryogenic techniques.
People of Medinice
Unlock access to complete
Funding Insights of Medinice
Medinice has successfully raised a total of $2.46M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $1.35 million completed in September 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Medinice
Investment portfolio details for Medinice
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Medinice
Detailed financials for Medinice
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medinice Comparisons
Peer comparison for Medinice
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Medinice
Detailed competitors of Medinice
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medinice
Complete news archive for Medinice
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medinice
Medinice was founded in 2012 and raised its 1st funding round 5 years after it was founded.
Medinice is headquartered in Kielce, Poland. It is registered at Kielce, Swietokrzyskie, Poland.
Medinice is a funded company, having raised a total of $2.46M across 2 funding rounds to date.
Annual revenue of Medinice is $45.69K as on Dec 31, 2024.
Medinice was established in 2012 and is based in Kielce, Poland. Operations are centered on a digital platform that facilitates the development of medical devices within the healthcare technology sector. Services include tools and resources for design, prototyping, and regulatory compliance, aiding innovators and manufacturers. The focus remains on streamlining processes for medical product advancement across European markets.
Medinice offers PacePress and CoolCryo.
Yes, Medinice is publicly traded on GPW under the ticker symbol ICE.
The ticker symbol of Medinice is ICE on GPW.